[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "International vaccine implications", "description": "WHO\n\nhttps://www.dw.com/en/coronavirus-who-approves-sinovac-covid-vaccine-for-emergency-use/a-57750495\n\nApproved Sinovac Biotech (CoronaVac) for emergency use\n\nSupplying Cambodia\n \nInactivated \n \nGrown in cell cultures, monkey kidney cells\n\nBeta-propiolactone\n\nReplication deficient\n\nProteins remain intact\n\nTwo dose\n\nNow part of COVAX, but no deal yet\n\nCapacity, 2 billion doses per year\n\nPhase 3 data, efficacy, 51 \u2013 91% in blocking infections\n\nTurkey, efficacy, 91.25% \n\nBrazil, 51%\n\nBrazil, 83.7% in preventing medical treatment\n\nBrazil, all deaths\n\nIndonesia, HCWs, n = 120,000, 94% effective at preventing symptomatic illness\n\nSinopharm (inactivated) already approved in April\n\nOthers WHO approved\n\nBioNTech-Pfizer, Moderna, AstraZeneca, Johnson & Johnson.\n\nSecretary of State Antony Blinken\n\nhttps://www.washingtonpost.com/national-security/blinken-coronavirus-latin-america/2021/06/01/b5ed2e10-c32c-11eb-8c18-fd53a628b992_story.html\n\nGlobal distribution soon\n\nLatin America\n\nChina, 165 million doses to Latin America and Caribbean\n\nSometime in the next week to two weeks we will be announcing the process by which we will distribute those vaccines\n\nPresident Biden, 80 million global doses by end of June\n\nChina\n\nhttps://www.washingtonpost.com/nation/2021/06/02/coronavirus-covid-live-updates-us/\n\nMay 31, 22.3 million doses given\n\nDoses so far, 660 million\n\nBeijing\u2019s vaccination program got off to a slow start but has rapidly picked up pace: \n\nChina now six times faster than US peak in April\n\nStrict border controls still in place\n\nNorth Korea \n\nhttps://www.reuters.com/article/health-coronavirus-northkorea/update-1-skorea-says-vaccine-shipment-to-nkorea-from-covax-delayed-again-idUSL2N2NK01H\n\nSouth Korea COVAX delivery not made yet\n\n2 million doses of AstraZeneca\n\nGlobal Alliance for Vaccines and Immunization (GAVI)\n\nFuture Proof report (Centre for Long-Term Resilience)\n\nhttps://drive.google.com/file/d/1LHn3nzxF2p68SfhwiPLCb5FMaMLq1dk6/view\n\nExtreme risks\n\nGlobal catastrophic risks\n\nExistential risks\n\nSpecific risks\n\nBiosecurity\n\nArtificial intelligence\n\nClimate change\n\nNuclear security\n\nBiosecurity\n\nDNA synthesis machines\n\nGene editing\n\nGain of function\n\nThrombocytopenia in mice reported in 2006\n\nBlood, (2006)\n\nhttps://ashpublications.org/blood/article/109/7/2832/125650/Adenovirus-induced-thrombocytopenia-the-role-of\n\nThrombocytopenia has been consistently reported following the administration of adenoviral gene transfer vectors. \n\nAll mice received virus through a single tail vein injection", "link": "https://www.youtube.com/watch?v=YqK77o_ve4g", "date_published": "2021-06-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]